ImpiloAmalungiselelo

Umuthi 'Rinofluimutsil': Izibuyekezo

Umuthi 'Rinofluimutsil "isetshenziswa ENT umkhuba futhi has a action vasoconstrictor futhi mucolytic. Kuyinto Antioxidants based futhi izingxenye elwa namagciwane anomthelela yokukhululwa acinene ukuminyana. Acetylcysteine, okuyinto eziqukethwe ukulungiselela, liquefies isikhwehlela. Umuthi 'Rinofluimutsil "has Izibuyekezo okuxubile kakhulu. Omunye kuyasiza cishe ngokushesha (ngisho ne sinusitis eqinile, okuyinto "enganikanga" nezinye medikametam), kanti abanye bathi akazange asize nhlobo. Ngoba umuntu izidakamizwa isibe iyithuluzi elibalulekile, kodwa othile bezisola imali wachitha. By the way, intengo kunalokho enkulu izidakamizwa.

Medicine "Rinofluimutsil" izingane Izibuyekezo icishe okufanayo. Imiphumela elisetshenziswa ngezindlela ezihlukahlukene ngakho. Abantu abaye basebenzisa izidakamizwa, kululekwa ukuyisebenzisa njengoba lehla kunokuba isifutho. Kusolwa ukuthi kuyaphumelela kakhulu ngaleyo ndlela. Umuthi "Izibuyekezo Rinofluimutsil ' posted kumawebhusayithi eziningi, ukuze ukwazi ukufunda uma ufuna. Ungase futhi ufunde kabanzi mayelana yonke imiphumela emibi, okuyinto ingatholakala kulesi sihloko. Zonke contraindications izidakamizwa iqukethe "Rinofluimutsil" imfundiso. imithi Izibuyekezo kuyinto omuhle uma izidingo ezilandelayo ngoba uhlelo lwayo lokusebenza. Ukucacisa incazelo ephelele zonke nemiphumela ebuhlungu ukuthi kungalindeleka zabantu usebenzisa izidakamizwa.

imiphumela engeziwe enqabayo kungenzeka nazo tachycardia, eliqhaqhazelayo futhi ngakhula blood pressure. Lokhu kungenxa kwenye yezingxenye ekulungisweni - tuaminogeptanom. Uphinde obhekene ukuvela imizwa yokukhathazeka. Ngaphezu kwalokho, lo izidakamizwa kungakwenza umlutha. Ngenxa ukusetshenziswa eside kungase kukhinyabeze ukusebenza kahle acinene nolwelwesi lwamafinyila. Uma ukwamukela okungalungile kungadala kome umlomo, pharynx futhi acinene. Ingxenye izidakamizwa "Rinofluimutsil" impendulo engakhi ehambisana izenzakalo ezinjalo. A kancane - ne nokuntuleka kwamakhono ayo. Ukuze ugweme imiphumela emibi, umuthi kumele sisetshenziswe izinsuku ezingaphezu kwezingu-7. umthamo Adult ongashadile emibili yokunyathelisa ku-valve, izingane - isikhathi. Ngosuku ungasebenzisa spray 3-4 izikhathi, hhayi ngaphezulu. Ngemva kwesonto ukwelashwa usebenzisa imithi kufanele wayeka, kungakhathaliseki yayisiza noma cha. Ukuphumelela lomuthi incike kumuntu ngamunye. Imiphumela engemihle ingase futhi ibe umuntu, ikakhulu abantu abathile nokungababekezeleli izingxenye ngabanye kwenzeka nomuthi "Rinofluimutsil" (nokubuyekeza ukuchaza zindlela zokusabela).

Umuthi oluphakeme eyaziwa kahle futhi esakazwa kabanzi. Nokho, ukuze ngokugcwele, kudingeka bazame ukukwenza practice. Medicine "Rinofluimutsil" has okubuyayo uma usebenzisa yonke imithetho nokuhambisana umthamo. Umuthi ayivunyelwe zisebenza thyrotoxicosis kanye engela-Ukuvalwa ukufiphala kanye uma kukhona ukungabekezeleli ngabanye izingxenye izindlela. Phakathi nokukhulelwa kanye lactation imithi "Rinofluimutsil" kusetshenziswe ngokuqapha. Uma kukhona izidakamizwa okunye, akukuhle ukuyisebenzisa. Izingane ezingaphansi kweminyaka emibili zomuthi is hhayi Kunconywa, Nokho, ezimweni ezibucayi, ingasetshenziswa. Izingane kudingeka lona ngokucophelela okukhulu ukuze singathwesi kulandele side effects (kuphela ngemva kokuthintana nodokotela wezingane zakho noma Laura).

Ngo bronchial ufuba nasekulweni angina pectoris kanye nomfutho wegazi ophezulu, umuthi kungcono hhayi ukusebenzisa. Lokhu kungenxa yokwakheka izidakamizwa, ezingasetshenziswa ukuthuthukisa izimpawu salezi zifo. Uma kukhona isidingo ukusebenzisa amathuluzi, ngaphambi kokuthatha kangcono ukuvakashela udokotela. Inkomba esiyinhloko ukusetshenziswa kwezidakamizwa - sibonakala ngezindlela ezahlukene rhinitis futhi sinusitis. Lapho komzimba, imithi kungcono ukuyeka futhi kudokotela. Bheka owelapha efiselekayo nje ngaphambi ukusebenzisa, ukuvimbela zonke izinhlobo imiphumela engemihle.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 zu.atomiyme.com. Theme powered by WordPress.